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Abstract Otitis media (OM) is the most prevalent
childhood disease in developed countries. Involvement
of innate immunity mediated by Toll-like receptors
(TLRs) in OM has been implicated primarily in cell
lines and by association studies of innate immune gene
polymorphisms with OM prevalence. However, the
precise role of innate immunity in OM is incompletely
understood. We review recent research that has advanced
our understanding of how innate immunity in the middle
ear is mediated by the interaction of pathogen molecules
with receptors such as the TLRs, leading to the
activation of adaptor molecules and production of
proinflammatory cytokines. TLR genes and signaling
molecules are upregulated in OM in a murine model.
Deletion of several key innate immune genes results in
persistent OM in mice, coupled with an inability to clear
bacterial infection from the middle ear. It is concluded
that an intact innate immune signaling system is critical
to recovery from bacterial OM.
Keywords Pathogenesis . Innate immunity . Otitis media .
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Introduction
Otitis media (OM) is one of the most prevalent diseases
of childhood and a major public health problem
contributing to childhood mortality in developing
countries [1]. In more developed societies, OM accounts
for more office visits and drug purchases than any other
childhood disease and has an estimated annual cost of
more than 5 billion dollars [2, 3].
Acute OM typically resolves swiftly, but patients
suffering from chronic, recurrent OM may suffer long-
term conductive hearing loss and permanent hearing loss
due to scarring of the middle ear conductive apparatus and
sensorineural damage to the inner ear. The reasons for the
chronicity of middle ear disease in 10% to 20% of children
are not clear. However, although many factors can
contribute to OM [4, 5], bacterial infection is considered
to be a dominant etiology, producing inflammation charac-
terized by mucosal hyperplasia, effusion, and leukocytic
infiltration of the middle ear [6, 7].
The most commonly isolated bacteria in OM are
nontypeable Haemophilus influenzae, Streptococcus pneu-
moniae, and Moraxella catarrhalis. Since the advent of
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pneumococcal vaccines, nontypeable H. influenzae has
become the most prevalent of these [8]. Bacteria, including
nontypeable H. influenzae, activate innate immune recep-
tors that are considered a key component of innate
immunity, providing the first line of host defense against
infection [9, 10]. Whereas middle ear responses to innate
immune ligands such as lipopolysaccharide (LPS) and
bacterial lipoproteins are well-documented, the role played
by innate immune receptors and their downstream signaling
molecules in OM is not yet fully understood. The present
review focuses on the role of innate immunity in OM
pathogenesis and recovery against the background that
Toll-like receptor (TLR) deficiencies have been shown to
induce significant abnormalities in the recovery from
bacterial infection at other locations [11, 12].
Otitis Media Treatment
As noted above, OM is a very common condition, but
optimal treatment is currently under considerable discus-
sion. In uncomplicated, acute OM, antibiotic therapy is no
longer recommended [13] because despite short-term
benefit, evidence-based studies show only minimal long-
term improvement in the recovery rate [14]. Only for more
serious, exacerbated OM is antibiotic therapy currently
prescribed. Persistent, recurrent, and chronic forms of OM
affect about 15% of children and represent a more difficult
problem. Prophylactic antibiotic treatment may fail to
resolve chronic OM and increases the burden of antibiotic
resistance to therapy [15]. Ventilation tubes can be effective
in the treatment of chronic/recurrent OM, but they are not
always effective and there is controversy regarding long-
term benefit and the potential for late adverse outcomes
such as tympanic membrane abnormalities.
Etiology and Pathogenesis of Otitis Media
The development of more effective treatments is compli-
cated by the fact that OM seems to be a multifactorial
disease. Obstruction of the eustachian tube with resultant
negative pressure and exudation of serum seems to be a
major factor [16]. Bacterial infection via the eustachian
tube, perhaps facilitated by the presence of serum as a
growth medium, is also well-recognized as a component in
this complex etiology. OM is strongly associated with
prior upper respiratory viral infection [15], which
increases the likelihood of subsequent bacterial middle
ear infection for reasons that are unclear but could include
increased bacterial adherence in the nasopharynx and
reduced ciliary activity in the eustachian tube. Inflamma-
tory reactions associated with immune response to
bacterial antigens, bacterial polysaccharides, and disorders
of inflammatory pathways, such as the cytokine network
and the complement cascade, may also contribute to OM
pathogenesis, especially in its chronic forms. The complex
etiology of OM may explain why susceptibility and
treatment outcomes can be so variable, and why OM is
self-limiting in most children but becomes persistent in
others. However, the central role of infection in OM
suggests that immunity may be a key to OM resistance
and resolution.
Immunity can involve the sensitization of lymphocytes
to recognize particular molecular patterns, or epitopes, a
process known as cognate immunity. After sensitization,
these cells can mount an efficient adaptive immune
response whenever the epitope is subsequently encoun-
tered. However, another form of immunity, termed innate
immunity, does not require prior experience. A significant
portion of such innate immunity is mediated by cellular
receptors that are genetically encoded to respond to specific
types of molecules produced by pathogens. Because they
operate without the need for prior sensitization, these
receptors form a critical first line of defense against
infection.
Immune Response in the Middle Ear
Resistance to infection of the middle ear is the basis for
avoidance of OM and, if infection ensues, recovery from
middle ear disease. As at other locations, such resistance
entails a cooperative response involving innate and
adaptive immunity. However, as very few lymphocytes
are found in the healthy middle ear, innate immunity
presumably mediates the initial host response to and
defense against infection [16]. This allows the middle ear
to clear many infections rapidly, before significant cognate
immune response has the opportunity to develop. This is
especially important in the middle ear, as adaptive
immunity appears to be poorly sensitized by antigen that
is first presented at this site [16]. In contrast, existing
systemic immunity is very strongly expressed in the
middle ear. In animals that have been systemically
immunized, antigenic challenge of the middle ear triggers
an immediate and massive middle ear response of IgG.
This is associated with a transudation of serum and
infiltration by lymphocytes from peripheral blood [16].
However, in a naïve host, until an adaptive immune
response is finally generated, innate immune responses
bear the burden of protecting the middle ear against
bacterial invasion. Moreover, it also has been shown at
other locations that signaling through innate immune
receptors is required for the effective sensitization needed
to generate adaptive immunity [17•]. It can be presumed
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that this is also true in the middle ear, and deficiencies in
innate immunity might be expected to lead to increased
incidence, severity, and duration of OM.
Innate Immune Signaling
Multiple cell types, particularly those that interact with the
external environment, express innate immune receptors,
including the TLRs. TLRs are found on or within surface
epithelial cells, mast cells, and dendritic cells, which are
prominent at mucosal surfaces such as that lining the
middle ear. TLRs are members of the pattern-recognition
receptors family that detect specific molecules associated
with microbial pathogens. Their activation leads to the
mobilization of other innate immune molecules such as
cytokines, chemokines, and interferons (IFNs), as well as
proteases, defensins, collectins, lysozyme, lactoferrin, and
other antimicrobial intermediates.
TLRs are evolutionally conserved and act as the first
line of host defense against infection. In general, TLRs
belong to the family of type I transmembrane receptors,
which are characterized by an N-terminal extracellular
leucine-rich repeat domain and a cytoplasmic Toll/
interleukin (IL)-1 receptor (TIR) domain [18]. To date,
13 TLRs have been identified in mammalian organisms,
each of which seems to mediate distinct functions in
pathogen recognition. TLR activation results in the
recruitment and activation of adaptor molecules, which
include myeloid differentiation factor-88 (MyD88) and
TIR domain containing adaptor inducing IFN-β (TRIF).
All TLRs except TLR3 can signal via the MydD88-
dependent pathway, leading, via nuclear factor-κB (NF-
κB) activation, to the production of proinflammatory
cytokines such as tumor necrosis factor (TNF) and the
ILs. The MydD88-independent TRIF pathway is dominat-
ed by the production of type I IFNs via IFN regulatory
factor-3, although it also induces delayed cytokine gene
expression [19]. These mediators are key components of
the innate immune response and prepare to initiate the
subsequent adaptive immune responses via leukocyte
chemotaxis and activation of lymphocytes.
Toll-Like Receptors in Otitis Media
Nontypeable H. influenzae, one of the most common
isolated pathogens of human OM, activates TLR signaling
pathways. Nontypeable H. influenzae contains molecular
patterns that serve as ligands for several TLRs. Peptidogly-
cans and peptidoglycan-associated proteins, such as outer
membrane protein P6, are ligands for TLR2 [20], which
frequently forms heterodimers with TLR1 or TLR6.
Lipooligosaccharide, closely related to LPS, activates
cellular signals via TLR2 and TLR4 [21]. Injection of
peptidoglycan or LPS into the middle ear can mimic
pathological changes of OM: mucosal inflammation,
leukocytosis, edema, middle ear pressure abnormalities,
and an infiltrate of macrophages into the subepithelial space
[22, 23]. Whereas middle ear responses to these TLR2 and
TLR4 ligands have long been recognized, the role played
by TLR receptors in infection-mediated OM pathogenesis
has only recently been addressed.
For example, an association between polymorphisms
in TLRs and their co-receptor, CD14, with OM prone-
ness has been described in children [24, 25]. Poly-
morphisms in the anti-inflammatory cytokine IL-10,
which often opposes the proinflammatory results of TLR
signaling, are also associated with increased incidence of
OM [24].
In middle ear epithelial cell lines, nontypeable H.
influenzae induces TLR2 expression [20], and the activa-
tion of TLR2 leads to the expression of proinflammatory
cytokines and mucin genes [26, 27].
Experimentally, reduced short-term responses to non-
typeable H. influenzae from 6 h to 3 days were reported in
the middle ears of C3H/HeJ mice, which express a
nonfunctional TLR4 [28]. However, because TLR deficien-
cies have been shown to induce significant abnormalities in
the recovery from bacterial infection at other sites [11, 12],
longer-term studies of nontypeable H. influenzae-induced
OM were undertaken. They demonstrated that TLR
signaling is critical for efficient host defense of the middle
ear.
Genes involved in innate immune responses were
identified that, when absent, result in transition from the
self-limiting characteristic of acute OM to persistent middle
ear disease in mice [29, 30]. These genes include those
encoding members of the TLR family itself, such as TLR2
and TLR4. In addition, defects in genes for the TLR
signaling molecules MyD88 and TRIF, as well as the
important downstream target molecule TNF, result in
abnormal OM recovery. The effects of these gene defects
underscore the importance of innate immune responses to
the normal processes of OM resolution.
Altered Otitis Media in Toll-Like Receptor-Deficient
Mice
Recent data illustrate a critical role for TLR2 and TLR4
signaling via a MyD88-dependent pathway in the middle
ear inflammatory responses to bacteria, and they are
particularly important during the recovery process from
OM. However, the individual TLRs appear to play quite
different roles.
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Mucosal Hyperplasia
A hallmark of OM is hyperplasia of the middle ear mucosa,
which transitions from a single layer of simple squamous
epithelial cells and a rudimentary stroma to a pseudostra-
tified respiratory epithelium with extensive stroma during
OM [29]. After inoculation of the middle ear with non-
typeable H. influenzae, wild-type mice display significant
thickening of the middle ear mucosa at day 2 (Fig. 1).
Mucosal thickness recovers and the middle ear is histolog-
ically normal by day 10. In contrast, while mice with
deficiencies in TLR2 or MyD88 initially show similar
initial increases in mucosal thickness, the mucosa in such
mice continues to increase in thickness and fails to return to
normal for at least 3 weeks after inoculation with non-
typeable H. influenzae (Fig. 1). Mice deficient in TLR4 or
TRIF exhibit more modest delays in mucosal recovery.
Leukocyte Recruitment and Function
Although there are few leukocytes in the resting middle ear,
these cells enter the tympanic cavity in large numbers
during OM. Inflammatory infiltrates during bacterial OM
consist primarily of neutrophils and macrophages, with
neutrophils dominating the first 24 h after inoculation, and
macrophages predominant from 48 to 72 h. Most cells leave
the normal middle ear by 5 days after initial infection. In
the absence of TLR2 or MyD88, initial neutrophil
recruitment is significantly delayed; however, neutrophils
that do enter the ME persist in TLR2 or MyD88-deficient
mice longer than in wild-type mice. Macrophage recruit-
ment is also delayed in TLR2- and MyD88-deficient middle
ears. However, in response to bacterial infection, these cells
eventually enter the middle ear in far greater numbers and
persist far longer than in wild types. TLR4- and TRIF-
deficient mice exhibit modest delays in middle ear
recruitment or clearance of neutrophils and macrophages.
Bacterial Clearance and Toll-Like Receptor Signaling
Mice deficient in TLR signaling display distinct deficits in
bacterial clearance after infection with nontypeable H.
influenzae (Table 1). In wild-type mice, culture-positive
middle ears increased from four of six on day 1 after
inoculation to six of six on day 2 and dropped to three of
six on day 3. Thereafter, bacteria have been cleared from
the middle ear, and nontypeable H. influenzae can no
longer be cultured from them. TLR2–/– middle ears were
culture positive throughout the 21-day observation period,
with two to three of six positive middle ears from 1 to
21 days after inoculation. All MyD88–/– middle ears were
culture positive from 1 to 14 days after inoculation. At days
21 and 42, two of six middle ears were positive. In contrast,
TLR4–/– and TRIF–/– middle ears display culture positivity
similar to that of wild types.
The middle ears of TLR2- and MyD88-deficient mice
thus fail to clear nontypeable H. influenzae despite the
presence of large numbers of macrophages, which might
be expected to phagocytose and kill bacteria. However,
when bacterial phagocytosis and intracellular killing of
nontypeable H. influenzae were evaluated in macrophages
isolated from MyD88–/– and TNF–/– mice, these processes
were found to be severely deficient in both genetic-
deficient mice [29, 30].
Toll-Like Receptors and Otitis Media Pathogenesis
TLRs, MyD88, and TRIF are known to play crucial roles in
inflammatory responses to nontypeable H. influenzae [20,
26]. However, neither TLRs nor their signaling molecules
singly appear to be essential for the initial expression of
nontypeable H. influenzae-mediated inflammation in the
middle ear. Both mucosal hyperplasia and leukocyte
infiltration are similar to controls in all the knockouts
studied (days 1–3). This presumably reflects the presence of
multiple innate immune receptors, including alternative
TLRs such as NOD-like receptors, as well as bacterial
DNA receptors, in the middle ear.
Although the initial phases of OM do not depend on
TLRs, the striking increase in duration of OM shows that
MyD88 and TLR2 are particularly critical to the process of
middle ear recovery from infection. This is closely related
to failure of bacterial clearance, especially in MyD88-null
Fig. 1 A quantitative evaluation of mucosal thickness in the middle
ear cavity throughout the course of otitis media. Mucosal thickness is
greater in mice lacking key Toll-like receptor (TLR) signaling genes
than in wild-type (WT) mice (n=6–8 middle ears per time point). Bars
represent the mean ± SEM. aSignificantly different from WT
(P<0.05). MyD88—myeloid differentiation factor-88; NTHi—
nontypeable Haemophilus influenzae; TRIF—Toll/interleukin-1 recep-
tor domain containing adaptor inducing interferon-β
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animals. In the absence of clearance, prolonged inflamma-
tion mediated by bacteria presumably leads to prolonged
and increased hyperplasia and leukocyte recruitment.
Toll-Like Receptors and Inflammatory Cytokines
and Chemokines in the Middle Ear
The activation of TLRs in turn leads to the activation of
various transcription factors, such as NF-κB, that mediate
the expression of genes encoding inflammatory cytokines,
including TNF, IL-1β, IL-6, IL-10, and the chemokines
CXCL2 (macrophage inflammatory protein-2) and CCL3
(macrophage inflammatory protein-1a).
TNF is one of the major proinflammatory cytokines with
a plausible pathophysiologic role for this mediator in OM.
For example, in rats, transtympanic injection of TNF into
the middle ears induces a subsequent inflammation [31],
while administration of a TNF antagonist, such as soluble
TNF receptor type I, decreases the severity of LPS-, TNF-
and immune-mediated OM in these animals [32–35]. In
children, polymorphisms in TNF have been associated with
an increased incidence of OM [36]. Also, in mice, during
experimental OM, persistent inflammatory responses of
TLR2–/– and TLR4–/– mice were associated with an initial
lack of induction of TNF after infection [30].
Importantly, TNF is also known to regulate the expres-
sion of TLRs and of molecules essential for TLR signaling,
including NF-κB, via positive [9] and negative [37]
feedback mechanisms. TNF thus modulates innate immu-
nity and the complex networks of downstream cytokines
and chemokines, and participates in the orchestration of the
inflammatory response by controlling the migration,
activation, and biological properties of various effector
cells, particularly mononuclear phagocytes, and neutrophilic
polymorphonuclear leukocytes [38, 39]. TNF also directly
stimulates production of CCL3, a member of the CC
chemokine family known to be an important chemotactic
and regulatory agent for macrophages [40, 41].
TNF-deficient mice display abnormal OM that is similar
in many respects to that seen in TLR2 and MyD88
deficiency. Similarly to those gene deletions, TNF-null
macrophages exhibit reduced nontypeable H. influenzae
phagocytosis and killing [42•]. Because lack of TLR2 or
MyD88 results in reduced TNF induction in the middle ear,
this suggests that TNF is a major effector of TLR signaling
during experimental, nontypeable H. influenzae-induced
OM. However, application of recombinant TNF to TNF-
deficient macrophages does not result in restoration of
normal levels of phagocytosis and killing by these cells.
Interestingly, recombinant CCL3 not only restores MyD88-,
TLR2-, and TNF-deficient macrophage function to normal,
but it also reduces the deficit in OM recovery observed in
TNF-null mice [42•]. This identifies CCL3 as another key
TLR effector molecule in the middle ear, operating
downstream from TNF.
Toll-Like Receptor Interactions in the Middle Ear
Whereas mutation of the TLR renders Drosophila spp
highly susceptible to fungal and other infections [43],
mutation of individual TLRs in mammals has not been
found to be as deleterious, suggesting that there is a degree
of functional redundancy among mammalian TLRs [44].
Studies have demonstrated an interaction between TLRs
such that induction of TLR2 or TLR4 may enhance
expression of TLR4 or TLR2, respectively [45], and the
activation of TLR2 by the skin commensal bacteria
byproduct lipoteichoic acid leads to the expression of
Table 1 Impaired bacterial clearance of middle ears in mice deficient in Toll-like receptor signalinga
Day after
NTHi
C57 culture
+ MEs
C57,
mean CS
TLR2–/–
culture + MEs
TLR2–/–,
mean CS
TLR4–/– culture
+ MEs
TLR4–/–,
mean CS
MyD–/– culture
+ MEs
MyD–/–,
mean CS
TRIF–/– culture
+ MEs
TRIF–/–,
mean CS
1 4/6 4 3/6 4 4/6 2.3 6/6 4 4/6 4
2 6/6 3 3/6 1 4/6 1.3 6/6 4 5/6 3
3 3/6 1 3/6 2 3/6 3.3 6/6 4 3/6 2
5 0/6 0 2/6 1 4/6 3.5 6/6 4 1/6 1
10 0/6 0 3/6 1.3 3/6 2 6/6 4 1/6 1
14 0/6 0 3/6 2 1/6 1 6/6 2.7 0/6 0
21 0/6 0 3/6 1 0/6 0 2/6 2 0/6 0
a One culture plate was generated for each of 6 middle ears (MEs)/strains, and the number of plates that were positive for nontypeable Haemophilus
influenzae (NTHi) were evaluated. Mean bacterial colonization of the positive-culture plates was evaluated using semiquantitative analysis of bacterial
colonization (CS): 0 indicates no CFUs, 1 indicates 1 quadrant with CFUs, 2 indicates 2 quadrants with CFUs, 3 indicates 3 quadrants with CFUs, and 4
indicates 4 quadrants with CFUs. Data represent positive-culture plates out of 6
MyD—myeloid differentiation factor; TLR—Toll-like receptor; TRIF—Toll/interleukin-1 receptor domain containing adaptor inducing interferon-β
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negative regulator, TNF receptor-associated factor-1, which
in turn suppresses TLR3-dependent inflammation after skin
injury [46]. In the middle ear, genetic loss of TLR2 or
TLR4 is associated with prolonged and persistent OM.
Evaluation of middle ear gene expression in mutant mice
revealed that early TLR4 signaling is required for the
nontypeable H. influenzae-mediated upregulated expression
of TLR2 and is necessary to influence downstream
molecular targets TNF and IL-10. These findings demon-
strate a predominant role for TLR2 (as opposed to TLR4) in
nontypeable H. influenzae-induced OM, with TLR2 induc-
tion primed by nontypeable H. influenzae interaction with
TLR4 [30]. TLR4 signaling is required for the initial
expression of TLR2 in response to nontypeable H. influenzae
in wild-type mice, but other signaling mechanisms eventually
upregulate TLR2, even in the absence of TLR4.
Conclusions
In summary, TLR signaling is critical for the timely
resolution of bacterial OM. Expression of proinflammatory
cytokines and the activation of macrophages to phagocytose
and kill bacteria are severely disabled in mice lacking key TLR
signaling molecules. This leads to failure of bacterial clearance
and to persistent OM. OM recovery deficits are most prominent
when certain key elements of TLR signaling are absent,
particularly TLR2,MyD88, and TNF. This suggests a dominant
axis of TLR signaling in OM. However, it is noteworthy that
significant deficits in recovery from nontypeableH. influenzae-
induced OM were observed in mice lacking any of the
elements of TLR signaling that have been tested. This
suggests that the entire TLR signaling network must work in
concert to ensure timely recovery from OM. Outcome,
coupled with the existence of polymorphisms in TLR
signaling genes that have been associated with OM proneness
in patients may explain why so many children have difficulty
with recurrent, persistent, or chronic middle ear disease.
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